Management Insight Management Insight -Septrd 3.qxp_Layout:10 AM Page 1 Patently Disruptive

First Page		Document Content
Date: 2015-09-08 10:09:32 Patent law Business Patent Acorda Therapeutics Kyle Bass Biotechnology Chemical patent Economy Biogen		Management Insight Management Insight -Septrd 3.qxp_Layout:10 AM Page 1 Patently Disruptive Add to Reading List Source URL: www.xcelience.com Download Document from Source Website File Size: 244,46 KB Share Document on Facebook

	Trustee Lynn Schenk Lynn Schenk is an attorney and consultant in private practice with extensive public policy and business experience. She serves on the Board of Directors for Sempra Energy, Biogen Idec, the Scripps Re DocID: 1tNv2 - View Document
	The Institutional Embeddedness of High-Tech Regions: Relational Foundations of the Boston Biotechnology Community DocID: 1rqeK - View Document
	Management Insight Management Insight -Septrd 3.qxp_Layout:10 AM Page 1 Patently Disruptive DocID: 1qXNa - View Document
	May 20, Novartis Makes Changes to Pharmaceutical Division Novartis has announced changes to its Pharmaceuticals Division by creating two business units: Novartis Pharmaceuticals and Novartis On DocID: 1pLhY - View Document
	20141009_Karte_Schweiz_GZA_ DocID: 1pHFh - View Document